Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.31 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10679812 | 0.79 | ALDH1A1 (0.34) | MAPTESR1ESR2MAPK1ALDH1A1 | |
| SCHEMBL17798412 | 0.79 | ALDH1A1 (0.33) | MAPTESR1ESR2MAPK1ALDH1A1 | |
| SCHEMBL9242759 | 0.70 | TSHR (0.32) | TSHR | |
| SCHEMBL9473201 | 0.70 | ALDH1A1 (0.44) | MAPTMAPK1ALDH1A1TSHRTDP1 | |
| SCHEMBL3526796 | 0.69 | ESR1 (0.37) | MAPTESR1ESR2MAPK1NR1H2 | |
| SCHEMBL20328588 | 0.69 | ESR1 (0.37) | MAPTESR1ESR2MAPK1NR1H2 | |
| SCHEMBL29749402 | 0.69 | ESR1 (0.37) | MAPTESR1ESR2MAPK1NR1H2 | |
| SCHEMBL3888384 | 0.69 | ESR1 (0.37) | MAPTESR1ESR2MAPK1NR1H2 | |
| SCHEMBL2595602 | 0.69 | MAPT (0.38) | MAPTESR1ESR2NR1H2NR1H3 | |
| SCHEMBL29102850 | 0.67 | SMYD2 (0.34) | MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2668176-B1 | A NOVEL PROCESS FOR SYNTHESIS OF POLYPHENOLS | SPHAERA PHARMA PTE LTD (SG) | 2017-05-17 | — | — | EP | claimed |
| US-9428482-B2 | Process for synthesis of polyphenols | SPHAERA PHARMA PTE. LTD. (SG) | 2016-08-30 | — | — | US | claimed |
| US-20140031421-A1 | NOVEL PROCESS FOR SYNTHESIS OF POLYPHENOLS | SPHAERA PHARMA PTE. LTD. (SG) | 2014-01-30 | — | — | US | claimed |
| CN-116783160-A | Libraries of compounds | 中外制药株式会社 | 2023-09-19 | — | — | CN | disclosed |
| US-20230101138-A1 | POLYMER COMPOUND, METHOD FOR PRODUCING POLYMER COMPOUND, ADHESIVE COMPOSITION, CURED PRODUCT, METHOD FOR PRODUCING ADHESIVE COMPOSITION, AND METHOD FOR ADJUSTING ADHESION FORCE | NATIONAL INSTITUTE FOR MATERIALS SCIENCE (JP) | 2023-03-30 | — | — | US | disclosed |
| EP-4101870-A1 | POLYMER COMPOUND, METHOD FOR PRODUCING POLYMER COMPOUND, ADHESIVE COMPOSITION, CURED PRODUCT, METHOD FOR PRODUCING ADHESIVE COMPOSITION, AND METHOD FOR ADJUSTING ADHESIVE STRENGTH | National Institute for Materials Science (JP) | 2022-12-14 | — | — | EP | disclosed |
| EP-2668176-B1 | A NOVEL PROCESS FOR SYNTHESIS OF POLYPHENOLS | SPHAERA PHARMA PTE LTD (SG) | 2017-05-17 | — | — | EP | disclosed |
| US-9556140-B2 | Approach for synthesis of catechins | SPHAERA PHARMA PVT. LTD. (IN) | 2017-01-31 | — | — | US | disclosed |
| US-9428482-B2 | Process for synthesis of polyphenols | SPHAERA PHARMA PTE. LTD. (SG) | 2016-08-30 | — | — | US | disclosed |
| US-20150368223-A1 | NOVEL APPROACH FOR SYNTHESIS OF CATECHINS | EPIRIUM BIO INC. | 2015-12-24 | — | — | US | disclosed |
| US-20140031421-A1 | NOVEL PROCESS FOR SYNTHESIS OF POLYPHENOLS | SPHAERA PHARMA PTE. LTD. (SG) | 2014-01-30 | — | — | US | disclosed |
| EP-0714393-B1 | THIAZOLES AS ANTIVIRAL | PFIZER (US) | 1998-09-23 | — | — | EP | disclosed |
| US-5789408-A | Antiviral thiazoles | PFIZER INC. (US) | 1998-08-04 | — | — | US | disclosed |
| EP-0714393-A1 | THIAZOLES AS ANTIVIRAL | PFIZER INC. (US) | 1996-06-05 | — | — | EP | disclosed |
| WO-1995005378-A1 | ANTIVIRAL THIAZOLES | PFIZER INC. (US) | 1995-02-23 | — | — | WO | disclosed |
| US-5187286-A | LEUKOTRIENE-B4 DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE AS PHARMACEUTICAL AGENTS | SCHERING AKTIENGESELLSCHAFT (DE) | 1993-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140031421-A1 | NOVEL PROCESS FOR SYNTHESIS OF POLYPHENOLS | COMT, NQO1, SPR | MAPT 3090/4885ESR1 217/4885ESR2 592/4885 |
| US-20150368223-A1 | NOVEL APPROACH FOR SYNTHESIS OF CATECHINS | NQO1, COMT, NNMT | MAPT 3520/4885ESR1 261/4885ESR2 76/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.